ClinicalTrials.gg
CompletedNCT07795489Updated Sep 3, 2026

Vacuum-assisted Closure Versus Conventional Dressings in Infected Lower-limb Wounds

An interventional study of Vacuum-Assisted Closure (VAC) Therapy and Conventional dressing in Infected Wound and Diabetic Wound, sponsored by Sargodha Medical College. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Sargodha Medical College · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Jul 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 11 studies in Wound Infection with a site in Pakistan — 1 open to participants now, 1 under way, 1 of them phase 3. Wound Infection · Pakistan.

Enrollment
6th of 10
90 · median 93
Started
2025
with 2 others
No phase
8 of 11
none open now
Registered
11th of 11
by date
Lead sponsor
1 of 11
Sargodha Medical College

Among the 11 studies in Wound Infection with a site in Pakistan, this one is the 6th largest by enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2025, is one of 8 with no phase, and was the 11th registered.

Wound Infection

270 studies on the registry are indexed under Wound Infection; 33 are open to participants now.

Browse Wound Infection studies →

Open to participants now

1 of the 11 studies in Wound Infection with a site in Pakistan is open now. Recruiting first, the newest first:

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 23 Wound Infection studies recruiting now, 17 (74%) set no upper age limit and 1 (4%) stop at 75 or younger; 2 take children under 18; 2 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Wound Infection with a site in Pakistan, or all of them as a file.
02

Study summary

Wound healing is a complex and dynamic process that includes an immediate sequence of cell migration leading to repair and closure. Delayed wound healing or non-healing of ulcers is a significant health problem, particularly in older adults. Vacuum assisted closure (VAC) is a relatively new technology with applications in a variety of difficult to manage acute and chronic wounds. Literature showed that the outcomes of VAC is a better than other method. Therefore, this study has been planned. This Randomized controlled trial will be done at Department of General Surgery, Dr Faisal Masood Teaching Hospital, Sargodha for 12 months.Sample size of 90 cases; 45 in each groups will be included through Non-probability consecutive sampling and will be randomly divided into 2 equal groups. In group A, VAC will be applied to wound. In group B, conventional dressing will be applied on wound. Wound size after one week will be assessed. If wound will heal completely, then duration for complete healing will be noted. Success will also be noted. All the data will be recorded in proforma.All the data will be analyzed with SPSS version 25. Both groups will be compared by using independent samples t-test for duration of healing, and wound size after a week and chi-square test for success. P-value ≤ 0.05 will be considered as significant. Conclusion and recommendations will be made to obtain better results with high success rate, which will lead to better quality of life and early discharge of patients.

03

Conditions studied

  • Infected Wound
  • Diabetic Wound

Browse trials for

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult population aged 18 - 40 years.
  • Gender;both male and female.
  • Patients having infected wound of lower limb (as per operational definition).

Exclusion criteria

Exclusion Criteria:

  • > Recurrent cases (on medical record)

    • Patients with metabolic diseases, taking , with peripheral vascular disease, cancer.
    • Patients with complications such as septic shock, diabetic ketoacidosis, or kidney injuries (on medical record)
    • Patients whose vitals were unstable (on clinical examination and medical record)
    • Patients with any evidence of underlying bone osteomyelitis and (on medical record).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    VAC Therapy

    Participants will receive vacuum-assisted closure (VAC) therapy for management of infected lower-limb wounds.

    Device: Vacuum-Assisted Closure (VAC) Therapy

  • Active comparator
    Conventional Dressing

    Participants will receive conventional wound dressing for management of infected lower-limb wounds.

    Other: Conventional dressing

Interventions

  • DeviceVacuum-Assisted Closure (VAC) Therapy

    Application of vacuum-assisted closure (VAC) therapy to infected lower-limb wounds using negative pressure wound therapy, with appropriate wound preparation and dressing changes according to the study protocol."

  • OtherConventional dressing

    Routine conventional dressing of infected lower-limb wounds using standard wound-care techniques and appropriate dressing materials, with dressing changes performed according to the study protocol."

06

What researchers measure

Primary outcomes

  1. Change in wound size

    Time frame: 7 days after initiation of treatment

Secondary outcomes

  1. Treatment success rate

    Time frame: Within two weeks of treatment

Other outcomes

  1. Duration of treatment/complete healing

    Time frame: Treatment success rate within 2 weeks

07

Study locations

1 site
  • Dr Faisal Masood teaching Hospital Sargodha
    Sargodha, Punjab Province 40100, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Aug 2026, 12 months.

Of 59 non-industry interventional studies with no phase under Wound Infection, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 53. This study's 12 months is below that.

Counting every sponsor, half of 64 studies reached it within 19 months; a quarter within 13 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2026
First posted
Aug 31, 2026
StartActual
Jul 16, 2025
Primary completionActual
Aug 14, 2026
CompletionActual
Aug 24, 2026
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07795489
Lead sponsor
Sargodha Medical College
Responsible party
Sponsor
First posted
Aug 31, 2026
Start date
Jul 16, 2025
Primary completion
Aug 14, 2026
Completion
Aug 24, 2026
Last update
Sep 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion